to the diagnosis of
Epstein-Barr-virus-associated gastric
adenocarcinoma. Int. J. Cancer, 60(5), 642-4
(1995).
5. Debyser, Z. et al., Comparative evaluation of three
ELISA techniques and an indirect
to the diagnosis of Epstein-
Barr-virus-associated gastric adenocarcinoma. Int.
J. Cancer, 60(5), 642-4 (1995).
5. Debyser, Z. et al., Comparative evaluation of three
ELISA techniques and an indirect
to the diagnosis of
Epstein-Barr-virus-associated gastric
adenocarcinoma. Int. J. Cancer, 60(5), 642-4
(1995).
5. Debyser, Z. et al., Comparative evaluation of three
ELISA techniques and an indirect
receptor related to class I
histocompatibility molecules., Proc Natl Acad Sci U S A 89, 638- 642, 1992.
9. Palm, et al., J Mol Biol 82, 587- 588, 1974
10. Colman, et al., J Mol Biol 100, 257-
Muhammad Munir Chaudry, Ph.D.
President
This certificate is valid until July 31, 2024 and subject to renewal at that time.
Page 9 of 99
Product Name Product Code Halal-ID Product Certificate #
Muhammad Munir Chaudry, Ph.D.
President
This certificate is valid until July 31, 2023 and subject to renewal at that time.
Page 9 of 99
Product Name Product Code Halal-ID Product Certificate #
Comparative study of seeding methods for
three-dimensional polymeric scaffolds. J Biomed Mater Res
51, 642, 2000.
44. Alvarez-Barreto, J.F., and Sikavitsas, V.I. Improved mes-
enchymal stem cell seeding
F1926 356 FASLG M NP_000630.1, y n/d n/d
21 Androgen Receptor A9853 367 AR P NP_000630.1, y n/d y
642 RhoE R6153 390 RND3 M NP_005159.1 y y n/d
44 ATF-1 A7833 466 ATF1 P NP_005162.1 , y n/d n/d
47 ATM
F1926 356 FASLG M NP_000630.1, y n/d n/d
21 Androgen Receptor A9853 367 AR P NP_000630.1, y n/d y
642 RhoE R6153 390 RND3 M NP_005159.1 y y n/d
44 ATF-1 A7833 466 ATF1 P NP_005162.1 , y n/d n/d
47 ATM
F1926 356 FASLG M NP_000630.1, y n/d n/d
21 Androgen Receptor A9853 367 AR P NP_000630.1, y n/d y
642 RhoE R6153 390 RND3 M NP_005159.1 y y n/d
44 ATF-1 A7833 466 ATF1 P NP_005162.1 , y n/d n/d
47 ATM
Pur Rb IgG 200 µg 06-333
Anti-phospho-MAP Kinase1/2 (Erk1/2) H M R IP WB APur Sh IgG 100 µg 06-642
(Tyr180), polyclonal
Anti-phospho-MAP Kinase1/2 (Erk1/2) H R WR WB Pur Rb IgG 200 µg 07-467
P n/d y y
640 Retinoblastoma R6775 P y n/d n/d
641 phospho-Retinoblastoma (pSer795) R6878 M y y y
642 RhoE R6153 M y y n/d
643 RICK, C-Terminal R9650 P y y y
644 RIP (Receptor Interacting Protein) R8274
phospho-Retinoblastoma (pSer795) R6878 5925, 24708, 19645 RB1,Rb1 NP_000312.2,XP_344435.3,NP_033055.1 M y y y
642 RhoE R6153 74194, 390 Rnd3,RND3 NP_083086.1,NP_005159.1 M y y n/d
643 RICK, C-Terminal R9650 192656
Pur Rb IgG 200 µg 06-333
Anti-phospho-MAP Kinase1/2 (Erk1/2) H M R IP WB APur Sh IgG 100 µg 06-642
(Tyr180), polyclonal
Anti-phospho-MAP Kinase1/2 (Erk1/2) H R WR WB Pur Rb IgG 200 µg 07-467